Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Cancer Survivorship
Published in: Journal of Cancer Survivorship 6/2016

01-12-2016

Call for manuscripts: Digital technologies and cancer survivorship

Published in: Journal of Cancer Survivorship | Issue 6/2016

Login to get access

Excerpt

Digital technologies, including eHealth applications, online interventions and telecare are having a significant impact on how many chronic illnesses are evaluated, treated and managed over time. Journal of Cancer Survivorship is seeking papers for a Special Section (4–6 papers) of the journal that showcases how technology is changing the landscape of quality health care from evaluation to long-term survivorship. …
Metadata
Title
Call for manuscripts: Digital technologies and cancer survivorship
Publication date
01-12-2016
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 6/2016
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-016-0576-x

Other articles of this Issue 6/2016

Journal of Cancer Survivorship 6/2016 Go to the issue

OriginalPaper

Long-term health effects among testicular cancer survivors

OriginalPaper

Employment in French young adult survivors of childhood leukemia: an LEA study (for Leucemies de l’Enfant et de l’Adolescent—childhood and adolescent leukemia)

OriginalPaper

Understanding strength exercise intentions and behavior in hematologic cancer survivors: an analysis of the intention-behavior gap

OriginalPaper

Chronic condition clusters and functional impairment in older cancer survivors: a population-based study

OriginalPaper

The “Big C”—stigma, cancer, and workplace discrimination

OriginalPaper

Pancreatic cancer survivors’ preferences, barriers, and facilitators related to physical activity and diet interventions
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits